AYTU BIOPHARMA, INC Quarterly Operating Lease, Payments in USD from Q3 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Aytu Biopharma, Inc annual/quarterly Operating Lease, Payments history and growth rate from Q3 2019 to Q3 2023.
  • Aytu Biopharma, Inc Operating Lease, Payments for the quarter ending September 30, 2023 was $360K, a 0.84% increase year-over-year.
  • Aytu Biopharma, Inc annual Operating Lease, Payments for 2024 was $1.81M, a 26.2% increase from 2023.
  • Aytu Biopharma, Inc annual Operating Lease, Payments for 2023 was $1.44M, a 41.3% increase from 2022.
  • Aytu Biopharma, Inc annual Operating Lease, Payments for 2022 was $1.02M, a 118% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $360K +$3K +0.84% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q3 2022 $357K +$75K +26.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q3 2021 $282K +$187K +197% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-02-21
Q3 2020 $95K +$95K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q3 2019 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.